Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE)

Journal of the American College of Cardiology
Vasilios PapademetriouStudy on Cognition and Prognosis in the Elderly study group

Abstract

The aim of this study was to test the hypothesis that the angiotensin II type 1 receptor blocker (ARB) candesartan can reduce the risk of stroke in elderly patients with isolated systolic hypertension (ISH). Isolated systolic hypertension is the predominant form of hypertension in the elderly, and stroke is the most common cardiovascular (CV) complication. In the Study on Cognition and Prognosis in the Elderly (SCOPE), 4,964 patients age 70 to 89 years were randomly assigned to double-blind candesartan or placebo with open-label antihypertensive therapy (mostly thiazide diuretics) added as needed to control blood pressure. Of the 4,964 patients, 1,518 had ISH (systolic blood pressure >160 mm Hg and diastolic blood pressure <90 mm Hg). The present study is a predefined subgroup analysis of outcome results in the ISH patients. Of the ISH patients, 754 were randomized to the candesartan group and 764 to the control group. Over the study period, blood pressure was reduced by 22/6 mm Hg in the candesartan group and by 20/5 mm Hg in the control group (difference between treatments 2/1 mm Hg; p = 0.101 and 0.064). A total of 20 fatal/non-fatal strokes occurred in the candesartan group (7.2/1,000 patient-years) and 35 in the control gr...Continue Reading

References

Sep 24, 2002·JAMA : the Journal of the American Medical Association·Sverre E KjeldsenUNKNOWN LIFE (Losartan Intervention for Endpoint Reduction) Study Group
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Jun 21, 2003·Stroke; a Journal of Cerebral Circulation·Joachim SchraderUNKNOWN Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group

❮ Previous
Next ❯

Citations

May 16, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Antonio Alberto LopesEric W Young
Jan 7, 2009·Therapeutic Advances in Cardiovascular Disease·José Rafael RomeroAleksandra Pikula
Aug 24, 2012·Patient Related Outcome Measures·Artavazd TadevosyanVardan T Karamyan
Dec 31, 2010·Vascular Health and Risk Management·Maria Leonarda De Rosa
Jul 1, 2005·Future Cardiology·Sanne de VogelVasilios Papademetriou
Sep 12, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Maximilian WiesmannJurgen A H R Claassen
Jun 17, 2006·Diabetes, Obesity & Metabolism·Ingrid OsSuzanne Oparil
Jul 30, 2015·Oxidative Medicine and Cellular Longevity·Mark A LovellBert C Lynn
Jul 28, 2006·Current Medical Research and Opinion·Rainer Düsing
Mar 22, 2006·Expert Opinion on Therapeutic Targets·Dimitris P Papadopoulos, Vasilios Papademetriou
Aug 19, 2011·Expert Opinion on Drug Safety·Vivencio Barrios, Carlos Escobar
Jun 10, 2011·Expert Opinion on Pharmacotherapy·Alexander JoostPeter Walter Radke
Apr 25, 2008·Expert Opinion on Drug Metabolism & Toxicology·Barbara H Rosario, Timothy James Hendra
Aug 20, 2009·Expert Opinion on Drug Metabolism & Toxicology·Robyn Kondrack, Syed Mohiuddin
Jan 29, 2011·Clinical and Experimental Hypertension : CHE·Tetsuro ShishidoIsao Kubota
May 9, 2012·Clinical and Experimental Hypertension : CHE·Kazuki IshikuraUNKNOWN J-HOME-Morning Study Group
Jan 15, 2013·International Journal of Hypertension·Ethiraj DhanarajPramil Tiwari
Apr 8, 2006·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Björn Dahlöf
Apr 8, 2006·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Kwang Kon KohEak Kyun Shin
Apr 8, 2006·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Peter Trenkwalder
Apr 8, 2006·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Rainer Schulz, Gerd Heusch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.